dc.contributor.author | Kulle, Bettina | |
dc.contributor.author | Støer, Nathalie Charlotte | |
dc.contributor.author | Martinsen, Jan Ivar | |
dc.contributor.author | Ursin, Giske | |
dc.contributor.author | Weiderpass, Elisabete | |
dc.contributor.author | Thoresen, G. Hege | |
dc.contributor.author | Debernard, Karen A. Boldingh | |
dc.contributor.author | Karlstad, Øystein | |
dc.contributor.author | Pottegard, Anton | |
dc.contributor.author | Friis, Søren | |
dc.date.accessioned | 2022-07-26T06:39:59Z | |
dc.date.available | 2022-07-26T06:39:59Z | |
dc.date.created | 2019-06-20T15:24:29Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | BMJ Open. 2019, 9:e028504 (4), 1-7. | |
dc.identifier.issn | 2044-6055 | |
dc.identifier.uri | https://hdl.handle.net/11250/3008459 | |
dc.language.iso | eng | |
dc.title | Identification of potential carcinogenic and chemopreventive effects of prescription drugs: A protocol for a Norwegian registry-based study | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1-7 | |
dc.source.volume | 9:e028504 | |
dc.source.journal | BMJ Open | |
dc.source.issue | 4 | |
dc.identifier.doi | 10.1136/bmjopen-2018-028504 | |
dc.identifier.cristin | 1706528 | |
cristin.unitcode | 7502,3,2,0 | |
cristin.unitname | Avdeling for kroniske sykdommer og aldring | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |